Contraindications to Portacath Placement
While the ESMO guidelines do not explicitly list absolute contraindications to portacath placement, femoral vein insertion should be avoided due to significantly increased risks of infection and thrombosis unless other sites are contraindicated (e.g., superior vena cava syndrome) 1.
Relative Contraindications Based on Clinical Context
Anatomical and Vascular Contraindications
- Superior vena cava (SVC) syndrome - This represents one of the few scenarios where traditional insertion sites (internal jugular, subclavian veins) become contraindicated, potentially necessitating femoral access despite its higher risk profile 1
- Severe coagulopathy or uncorrected bleeding disorders - While not explicitly stated in guidelines, this represents a standard surgical contraindication given the invasive nature of the procedure
- Active infection at the proposed insertion site - Local skin or soft tissue infection would preclude safe device placement
Patient-Specific Factors Requiring Careful Assessment
The guidelines emphasize that careful preoperative assessment including medical history, physical examination, and appropriate laboratory/radiological tests is essential 1. This assessment should identify:
- Severe thrombocytopenia or coagulation abnormalities requiring correction before elective placement
- Bilateral upper extremity deep vein thrombosis limiting available insertion sites
- Previous radiation therapy to the chest wall that may compromise tissue integrity
- Anatomical abnormalities of the central veins identified on imaging
Clinical Pitfalls and Considerations
Risk Stratification for Complications
Recent evidence identifies specific patient populations at higher risk for port-related complications that warrant careful consideration:
- Low body mass index (BMI ≤20 kg/m²) is a significant risk factor for port infection requiring removal 2
- Male sex shows increased infection risk 2
- Ports intended primarily for total parenteral nutrition (TPN) have substantially higher infection rates and should be avoided or used only in exceptional circumstances 2, 3
Important Caveat About Port Usage
Ports should not be used for general intravenous access in non-specialty wards 3. The device is designed for intermittent, specialized use (primarily chemotherapy). Using a port for continuous or frequent general IV access:
- Transforms it into an external device, negating its main advantage
- Significantly increases complication risk
- May lead to device loss
- Requires repeated percutaneous punctures with extravasation risk
The exception is power-injectable ports for radiological contrast studies, which requires specific protocols 3.
Procedural Requirements to Minimize Risk
The guidelines mandate specific conditions for safe placement 1:
- Strict sterile conditions in the operating room (not bedside placement)
- Chlorhexidine solutions with alcohol for skin preparation
- No routine antimicrobial prophylaxis (not recommended)
- Radiological confirmation of catheter tip position (fluoroscopy or chest X-ray)
- Post-procedure monitoring including 4-hourly vital signs and chest X-ray if dyspnea or chest pain develops
Weight Considerations in Pediatrics
For pediatric patients, weight <10 kg is NOT a contraindication to port placement, as complication rates are not significantly different from larger children 4. Arbitrary weight cutoffs should not exclude small children from port placement when clinically indicated.